I do not know if I am doing this correctly. I’m trying to introduce myself and post about my circumstances. So, here goes:
HepBCommunity.org intro post
Hi Everyone. I’m very touched and grateful to Thomas Tu for founding this community and to everyone else here who keeps this forum alive. Thank you, all.
Please excuse the length of this introductory post. Like others, I stumbled upon this supportive forum serendipitously. I was seeking an understanding of my (56-year-old) chronic Hep B that I was given to believe was permanently dormant. Now I’m also trying to cope with and understand a cirrhosis diagnosis that I was only recently apprised of. I’m still in shock but not panicking (yet).
In the UK, c. 1968, I was infected with HBV and had an acute episode for about a week or so until jaundice and other symptoms cleared. The only treatment was convalescence; no follow up, advice or cautions.
I moved to Canada in 1975 and, c. 1990, was seen at my family clinic, by a (now retired) doctor, who ordered bloodwork that showed I was a chronic HBV carrier. There was no treatment, no referral to a specialist and apparently no cause for concern except to have my spouse tested (negative). Presumably, my ALT was normal (?) – there are no records readily available.
I do have records for 2008: ALT=30; MCH=34.1, Neuts=1.9. No follow up; and, 2012: ALT=36. Again, no follow up.
In April 2022, bloodwork ordered by the same family clinic (but different MD), again showed slightly abnormal RBC Indices: MCV=100, MCH=34.
In August 2022, I was hospitalised and diagnosed with bradyarrhythmia. Two separate blood panels were ordered and some results were pertinent to HBV:
-
Erythrocytes=4.38, MCH=33.6, Albumin=41, Creatinine=51.
-
MCV=99.1, MCH=33.5, Platelets=141, Creatinine=53.
In April 2023, the same MD at the same family clinic ordered more bloodwork:
RBC Indices: MCV=101, MCH=34, Platelets=152.
After asking him about the persistently abnormal RBC’s, he asked if there was a history of any liver issues. He was unaware of the HBV infection that the previous doctor had been monitoring, so ordered a liver panel, June 2023, and made a referral to an hepatologist. Bloodwork results as follows:
Hepatitis B DNA Viral Load 6.22E+1 IU/mL
Hepatitis B Surface Antigen: Reactive
Hepatitis B Core Total (IgG+IgM) Antibody: Reactive
Hepatitis B “e” Antigen: Non-reactive
Hepatitis B “e” Antibody: Reactive
Hepatitis C Antibody: Non-reactive
The hepatologist ordered more bloodwork in Oct 2023, plus an ultrasound in Nov 2023.
Quoted from her report: “Hemoglobin 157, WBC 5.6, PLT 160, INR 1.1, Bilirubin 7, Albumin 43, AST36, ALT29, ALP67, GGT18, AFP 3, Creatinine 71, EGFR 88, Glucose 5.0, Cholesterol 5.56, Triglyceride 2.53, HDL 1.47, LDL 3.0, Ferritin 238, Ceruloplasmin and Alpha-1antitrypsin levels-normal, Autoantibodies -negative, Quantitative immunoglobulins -normal TSH 2.25, Hepatitis A IgG antibody – positive”
The ultrasound summary is: Liver = 12.8 cm, heterogeneous echogenicity, mildly nodular capsule, no focal hepatic lesion. The pancreatic duct is mildly prominent measuring 0.3 cm, otherwise, normal appearance. Abdominal aorta: No aneurysmal dilatation. Gallbladder: Normal. The gallbladder wall = 0.2 cm. Common bile duct: The common bile duct = 0.6 cm, no dilatation. The right kidney = 9.1 cm with multiple parapelvic cysts. The left kidney measures 8.7 cm also with multiple parapelvic cysts. Spleen = 7.1 cm, no splenomegaly. OPINION: no focal hepatic lesion.
The Dec Fibroscan was performed at the hepatologists office. Paraphrasing her report: “19.4kPa=F4 early cirrhosis, CAP266dB/m=S2/3 in keeping with increased liver steatosis and suggestive of early cirrhosis. No other intra-abdominal pathology of note.”
She goes on to say, that she suspects that, in the past I may have had a prolonged period of liver inflammation that led to fibrosis, and that while there’s no evidence of ongoing inflammation, guidelines for patients with cirrhosis suggest an antiviral (Tenofovir 300mg o.d.) to decrease the risk of HCC
This is all brand new to me and somewhat confusing! Even more so because I’ve been reading papers and abstracts since December that, at one moment give me hope, and the next, dash it. I’m hoping that forum members can help me understand the results above.
While I’ll be 75 next month, from what I’ve read, I recognise I shouldn’t be lulled into complacency based on the lack of detectable symptoms for 56 years. I’m very concerned to learn of my cirrhosis and wonder if it is an inevitable progressive process, or if the hepatologist is correct about it having happened some time ago given the lack of ongoing inflammation at present. That is, can the scarring process just cease on its own?
Also, some assert that the liver can regenerate but not once scar tissue eventually interferes. This may be very naïve but how can you tell the degree of scarring? Is this measurable somehow, and what is the significance of stable ALT/AST in all of this?
I have follow-up bloodwork and an ultrasound booked for May. I’m considering having another Fibroscan if I can find a provider. My thinking is to treat the first one as a baseline. I have no idea if the results of an additional scan in just six months could show either worsening, improvement or stasis.
I’m a bit trepidatious when it comes to medication. I’ve barely used any over the years and presently use none. From other reading, apparently Tenofovir (nor anything else) can make one completely virus-free. Is this true? How is its efficacy measured? Is it undetectable viral load plus well-functioning enzymes? How would that be distinguished from a chronic carrier who already has those? (Not that I do.)
After using an antiviral, do you produce HBV Ab? Why do you have to take the antiviral for life? Is an antiviral actually a kind of “virus suppressor”? What does DNA Viral Load 6.22E+1 IU/mL actually mean? With a low viral load does it mean an antiviral could be more effective?
So many questions. Thank you in advance for taking the time to read this and for any clarification.